Principal Financial Group Inc Coherus Bio Sciences, Inc. Transaction History

Principal Financial Group Inc

$160 Billion
Q2 2024

A detailed history of Principal Financial Group Inc transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 17,372 shares of CHRS stock, worth $18,240. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,372

Previous 24,465 28.99%

Holding current value

$18,240

Previous $58,000 48.28%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$1.58 - $2.51 $11,206 - $17,803	-7,093 Reduced 28.99%	17,372 $30,000
Q1 2024 Apr 29, 2024	SELL	$2.02 - $3.14 $187 - $292	-93 Reduced 0.38%	24,465 $58,000
Q4 2023 Feb 07, 2024	BUY	$1.59 - $3.85 $279 - $677	176 Added 0.72%	24,558 $81,000
Q3 2023 Nov 02, 2023	SELL	$3.74 - $5.45 $1.38 Million - $2.02 Million	-369,858 Reduced 93.82%	24,382 $91,000
Q2 2023 Aug 07, 2023	SELL	$3.79 - $8.3 $31,123 - $68,159	-8,212 Reduced 2.04%	394,240 $1.68 Million
Q1 2023 May 09, 2023	SELL	$5.89 - $10.52 $53,805 - $96,100	-9,135 Reduced 2.22%	402,452 $2.75 Million
Q4 2022 Feb 09, 2023	SELL	$5.69 - $10.07 $112,013 - $198,238	-19,686 Reduced 4.56%	411,587 $3.26 Million
Q3 2022 Nov 09, 2022	SELL	$7.17 - $13.87 $283,444 - $548,308	-39,532 Reduced 8.4%	431,273 $4.15 Million
Q2 2022 Aug 10, 2022	SELL	$5.86 - $13.23 $118,026 - $266,465	-20,141 Reduced 4.1%	470,805 $3.41 Million
Q1 2022 May 09, 2022	SELL	$10.92 - $16.41 $313,032 - $470,409	-28,666 Reduced 5.52%	490,946 $6.34 Million
Q4 2021 Feb 09, 2022	SELL	$15.81 - $18.99 $1.96 Million - $2.35 Million	-123,670 Reduced 19.22%	519,612 $8.29 Million
Q3 2021 Nov 09, 2021	SELL	$12.68 - $17.79 $223,624 - $313,744	-17,636 Reduced 2.67%	643,282 $10.3 Million
Q2 2021 Aug 10, 2021	BUY	$12.95 - $15.41 $1.35 Million - $1.6 Million	103,886 Added 18.65%	660,918 $9.14 Million
Q1 2021 May 10, 2021	BUY	$14.42 - $21.39 $144,459 - $214,285	10,018 Added 1.83%	557,032 $8.14 Million
Q4 2020 Feb 08, 2021	SELL	$16.56 - $18.94 $566,418 - $647,823	-34,204 Reduced 5.88%	547,014 $9.51 Million
Q3 2020 Nov 06, 2020	BUY	$17.41 - $19.89 $852,271 - $973,675	48,953 Added 9.2%	581,218 $10.7 Million
Q2 2020 Aug 05, 2020	BUY	$14.43 - $19.16 $7 Million - $9.29 Million	485,108 Added 1028.71%	532,265 $9.51 Million
Q1 2020 May 12, 2020	BUY	$11.67 - $22.53 $7,340 - $14,171	629 Added 1.35%	47,157 $765,000
Q4 2019 Feb 05, 2020	BUY	$16.33 - $21.37 $583,144 - $763,122	35,710 Added 330.1%	46,528 $838,000
Q3 2019 Nov 13, 2019	BUY	$16.3 - $23.37 $2,885 - $4,136	177 Added 1.66%	10,818 $219,000
Q2 2019 Aug 12, 2019	SELL	$13.1 - $22.1 $91 - $154	-7 Reduced 0.07%	10,641 $235,000
Q1 2019 May 10, 2019	BUY	$8.38 - $15.5 $1,994 - $3,689	238 Added 2.29%	10,648 $145,000
Q1 2018 May 14, 2018	BUY	$9.1 - $13.7 $94,731 - $142,617	10,410 New	10,410 $115,000

Others Institutions Holding CHRS

# of Institutions

143

Shares Held

82.7M

Call Options Held

79.1K

Put Options Held

100K

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $81.6M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account

Principal Financial Group Inc Coherus Bio Sciences, Inc. Transaction History